Evidence map›Paper›PMID 40443003›Full record

ArticleJournal of managed care & specialty pharmacy2025

Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care.

Tyler D Wagner, Dave L Dixon, Yongyun Shin, Mikhail Dozmorov, Kerri T Musselman, Tonya M Buffington, Haroon Hyder, Bryan Kirschner, Resa M Jones, Teresa M Salgado

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tyler D WagnerCenter for Pharmacy Practice Innovation, Virginia Commonwealth University School of Pharmacy, Richmond.
Dave L DixonCenter for Pharmacy Practice Innovation, Virginia Commonwealth University School of Pharmacy, Richmond.
Yongyun ShinDepartment of Biostatistics, Virginia Commonwealth University School of Public Health, Richmond.
Mikhail DozmorovDepartment of Biostatistics, Virginia Commonwealth University School of Public Health, Richmond.
Kerri T MusselmanCKB Health Consulting LLC, Midlothian, VA.
Tonya M BuffingtonBon Secours Mercy Health, Richmond, VA.
Haroon HyderBon Secours Mercy Health, Richmond, VA.
Bryan KirschnerBon Secours Mercy Health, Richmond, VA.
Resa M JonesDepartment of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, PA.
Teresa M SalgadoCenter for Pharmacy Practice Innovation, Virginia Commonwealth University School of Pharmacy, Richmond.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidisciplinary primary care models incorporating pharmacists have emerged to improve glycemic control in patients with uncontrolled type 2 diabetes mellitus (T2DM). Healthcare Effectiveness Data and Information Set (HEDIS) measures establish quality benchmarks for comprehensive diabetes care and guide reimbursement. Large-scale research on the effect of pharmacist interventions to improve these quality measures in primary care remains limited.

objectiveTo evaluate the effectiveness of a pharmacist-physician collaborative care (PPCC) model on comprehensive diabetes care quality measure achievement compared with standard care (SC).

methodsThis retrospective cohort study included adults aged 18 to 75 years with uncontrolled T2DM receiving care in primary care clinics at a community-based health system in Virginia from July 1, 2018, to December 31, 2019. Patients were in one of 2 groups: (1) the intervention group (PPCC), where embedded pharmacists provided diabetes management under a collaborative practice agreement, and (2) the comparator group receiving SC in clinics without pharmacists. The SC group was created via 1:2 propensity score matching. Generalized linear mixed models assessed the association between group and quality measure achievement. Primary outcomes included glycated hemoglobin (hemoglobin A1c) (≤9%, ≤8%, ≤7%) and blood pressure control (<140/90 mm Hg), per the last recorded value in 2019.

resultsThe sample (N = 1,293) had a mean age of 57 years, was 56% female, and 45% each White and Black. The PPCC group (n = 431) was more likely to achieve A1c control compared with the SC group (n = 862) (A1c <9%: odds ratio [OR] = 3.68, 95% CI = 2.31-5.84; A1c <8%: OR = 3.53, 95% CI = 2.12-5.89; A1c <7%: OR = 4.61, 95% CI = 2.48-8.56; all

conclusionsPatients in the PPCC group were more likely to meet comprehensive diabetes care quality measures compared with SC. These results underscore the value of pharmacists in diabetes management in primary care and their contribution to value-based care.

Indexed as

Blood PressureDiabetes Mellitus, Type 2Glycated HemoglobinPatient Care TeamPharmacistsPhysiciansPrimary Health CareAdolescentAdultAgedFemaleHumansMaleMiddle AgedQuality Indicators, Health CareRetrospective StudiesGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID40443003
PMCPMC12123200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.